Jean Coutu profit rises 10 pct on higher generic drug sales

Thu Jan 10, 2013 6:35am EST

Jan 10 (Reuters) - Canadian pharmacy chain Jean Coutu Group Inc reported a 10 percent rise in third-quarter profit as sales at its generic drug manufacturing subsidiary, Pro Doc, rose.

Net profit for the quarter rose to C$56.2 million ($56.93 million), or 26 Canadian cents per share, compared with C$51.2 million, or 23 Canadian cents per share, a year earlier.

The Longueuil, Quebec-based company said revenue rose 2 percent to C$716.6 million. ()

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.